专利检索 ap:("Novartis AG") AND inv:"Monica Ligueros-Saylan" 第 1 页

1.

发明申请
USE OF IL-1beta BINDING ANTIBODIES 审中-公开

公开(公告)号：US20190048072A1

公开(公告)日：2019-02-14

申请号：US15970542

申请日：2018-05-03

申请人： Novartis AG

发明人： Monica Ligueros-Saylan , Patrice Matchaba , Tom Thuren , Paul Ridker , Peter Libby , Penelope OTTEWELL , Yi Yang LAU , Margaret DUGAN

IPC分类号： C07K16/24 , A61P35/00 , G01N33/574 , A61K9/00

摘要： Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.